CARL LEE FUGATE M.D. NPI 1326017013

NPI Details

Carl Lee Fugate, M.D. is a family medicine in Beloit, KS with 41 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Carl Lee Fugate, M.D. NPI is 1326017013. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:1984

The provider's business location address is:

1005 N LINCOLN AVE
BELOIT, KS
ZIP 67420-215
Phone: (785) 738-2246
Fax: (785) 738-4303

The NPI 1326017013 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood test, clotting time (HCPCS:85610)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Emergency department visit for problem of high severity (HCPCS:99284)
• X-ray of chest, 2 views (HCPCS:71046)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Vitamin d-3 level (HCPCS:82306)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Screening test for pathogenic organisms with colony count (HCPCS:87084)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Magnesium level (HCPCS:83735)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Emergency department visit for life threatening or functioning severity (HCPCS:99285)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Hospital observation care on day of discharge (HCPCS:99217)
• X-ray of both knees while standing (HCPCS:73565)
• Uric acid level, blood (HCPCS:84550)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Colonoscopy (HCPCS:NAN13)
• Upper gastrointestinal (GI) endoscopy for acid reflux (HCPCS:NAN12)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 3/15/2006 and was last updated on 4/23/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.